指南与共识术前评估与围术期医学

指南推荐术前负荷试验的预期发生率与费用

Anticipated Rates and Costs of Guideline-Concordant Preoperative Stress Testing.
指南 / 共识 · Anesth Analg · 2019-01-01

本研究将两种指南推荐的风险预测工具(修订心脏风险指数与心肌梗死或心脏骤停)应用于2009年美国多中心前瞻性手术患者注册数据,估算若医生遵循ACC/AHA指南时的术前负荷试验预期发生率与全国直接医疗支出(2017年美元),并分析两种工具的一致性,发现指南推荐支出可观且因工具与功能状态评估可靠性而异。

要点

  • 遵循指南的术前负荷试验支出可观,且因风险工具与功能状态评估可靠性差异显著。
  • 两种指南推荐风险工具在现行风险阈值下机会校正一致性差。
  • 术前负荷试验可能是重要医疗支出源,尽管获益未证实。

核心结论

  • 若遵循现行指南,术前负荷试验将是可观的医疗支出来源,尽管其获益尚未证实。

研究设计与样本

  • 将修订心脏风险指数与心肌梗死或心脏骤停两种风险预测工具应用于2009年美国多中心前瞻性手术患者注册数据。

主要发现

  • 指南推荐支出因所用风险预测工具及功能状态评估可靠性不同而差异显著。
  • “ elevated ”风险患者的检测率与支出可能远高于“低”风险患者。
  • 两种指南推荐工具在现行推荐风险阈值下机会校正一致性差。

临床怎么用

  • 临床选用何种围术期风险评估工具、何种风险阈值适合患者选择以及功能状态评估的可靠性均需进一步关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines recommend that patients have preoperative assessment of cardiac risk and functional status, and that patients at "elevated" cardiac risk with poor or unknown functional status be referred for preoperative stress testing. Little is known about current rates of testing or resultant medical costs. We set out to estimate the expected rates of preoperative stress testing and resultant costs if physicians in the United States were to follow current guidelines and to investigate differences that would arise from 2 risk prediction methods included in current guidelines. METHODS: We applied 2 risk prediction tools (Revised Cardiac Risk Index and Myocardial Infarction or Cardiac Arrest) included in current American College of Cardiology/American Heart Association guidelines to a multicenter prospective registry of patients undergoing surgery in the United States in 2009. We then calculated expected rates of preoperative cardiac stress testing if physicians were to follow American College of Cardiology/American Heart Association guidelines, expected nationwide direct medical expenditures that would result (in 2017 US dollars), and agreement beyond chance between the 2 risk prediction tools. RESULTS: Current guidelines recommend considerable spending on preoperative stress testing. Guideline-recommended spending would differ substantially depending on the risk prediction tool used and the reliability of the functional status assessment. Rates of testing and resultant spending are likely much greater among patients at "elevated" risk, compared with patients at "low" risk. Two guideline-recommended risk assessment tools, Revised Cardiac Risk Index and Myocardial Infarction or Cardiac Arrest, have poor agreement beyond chance across the currently recommended risk threshold. CONCLUSIONS: Preoperative stress testing is likely a considerable source of medical spending, despite unproven benefit. Which perioperative risk assessment tool clinicians should use, what risk thresholds are appropriate for patient selection, and the reliability of the functional status assessment all warrant further attention.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Pappas MA, Sessler DI, Rothberg MB, et al. Anticipated Rates and Costs of Guideline-Concordant Preoperative Stress Testing. Anesth Analg. 2019. PMID: 30169411. doi:10.1213/ANE.0000000000003754

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。